MEDGF (Medacta Group) Other Current Receivables: $0.9 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEDGF Medacta Group SA MEDGF
91 GF Score
Price $83.91
GF Value $100.71
! 2 Warning Signs
View Full Analysis

What is Medacta Group Other Current Receivables?

Medacta Group MEDGF 91 Other Current Receivables is $0.9 Mil as of Dec. 2025. GuruFocus rates MEDGF with a GF Score™ of 91/100 and a GF Value™ of $100.71. The stock has 2 warning signs investors should review.

Medacta Group's Other Current Receivables for the quarter that ended in Dec. 2025 was $0.9 Mil.

Medacta Group's quarterly Other Current Receivables declined from Dec. 2024 ($0.39 Mil) to Jun. 2025 ($0.00 Mil) but then increased from Jun. 2025 ($0.00 Mil) to Dec. 2025 ($0.93 Mil).

Medacta Group's annual Other Current Receivables increased from Dec. 2023 ($0.38 Mil) to Dec. 2024 ($0.39 Mil) and increased from Dec. 2024 ($0.39 Mil) to Dec. 2025 ($0.93 Mil).

Medacta Group Other Current Receivables Related Terms

Medacta Group Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Medacta Group's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medacta Group Other Current Receivables Chart

Medacta Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.81 0.38 0.39 0.93

Medacta Group Semi-Annual Data
Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.00 0.39 0.00 0.93
MEDGF
91GF Score
Medacta Group SA MEDGF
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medacta Group Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.9 Mil mean?
Medacta Group (MEDGF) has a Other Current Receivables of $0.9 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Medacta Group and its competitors.
Is Medacta Group's Other Current Receivables too high?
Medacta Group's current Other Current Receivables is $0.9 Mil. Overall, Medacta Group has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Medacta Group's Other Current Receivables compare to ABT and SYK?
Medacta Group's Other Current Receivables of $0.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Medacta Group and its competitors. Medacta Group's current Other Current Receivables is $0.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medacta Group stock overvalued right now?
Medacta Group (MEDGF) has a current Other Current Receivables of $0.9 Mil. The stock's GF Value™ is $100.71, compared to a current price of $83.91 — trading 16.7% below its estimated fair value. The current Other Current Receivables is $0.9 Mil. Medacta Group's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Medacta Group (MEDGF), the current Other Current Receivables is $0.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medacta Group (MEDGF) Overvalued in 2026?

Based on GuruFocus' analysis, Medacta Group stock appears to be undervalued. The current stock price of $83.91 is trading 16.7% below its estimated GF Value™ of $100.71.

Key valuation signals for MEDGF:

  • Other Current Receivables: $0.9 Mil
  • GF Value™: $100.71 vs. price of $83.91 (16.7% below fair value)
  • GF Score™: 91/100 with 2 warning signs

No single metric tells the full story. See the MEDGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medacta Group Business Description

Address Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is involved in developing, manufacturing, and distributing orthopedic and neurosurgical medical devices. It specializes in the design, production, and distribution of personalized and sustainable solutions for joint replacement, sports medicine, and spine surgery. Medacta's product portfolio includes hip, knee, shoulder, and spine replacement solutions, along with a comprehensive range of sports medicine. Its products and surgical techniques are supported by an extensive program of surgeon education and engagement initiatives, enabling its offerings to be effective for the patient and surgeon. Geographically, the company derives maximum revenue from EMEA (which includes Europe, Middle East and Africa), followed by North America, Asia-Pacific, and the Latin America markets.
91GF Score

Get the complete analysis for MEDGF

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$83.91
Price
$100.71
GF Value